ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

DNK Danakali Limited

20.00
0.00 (0.00%)
28 Mar 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Danakali Limited LSE:DNK London Ordinary Share AU000000DNK9 ORDS NPV
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 20.00 19.00 21.00 0.00 00:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Danakali Limited Appendix 3B (9264T)

26/03/2019 7:00am

UK Regulatory


Danakali (LSE:DNK)
Historical Stock Chart


From Mar 2019 to Mar 2024

Click Here for more Danakali Charts.

TIDMDNK

RNS Number : 9264T

Danakali Limited

26 March 2019

Rule 2.7, 3.10.3, 3.10.4, 3.10.5

Appendix 3B

New issue announcement,

application for quotation of additional securities

and agreement

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.

Introduced 01/07/96 Origin: Appendix 5 Amended 01/07/98, 01/09/99, 01/07/00, 30/09/01, 11/03/02, 01/01/03, 24/10/05, 01/08/12, 04/03/13

 
Name of entity 
 DANAKALI LTD 
 
 
ABN 
 56 097 904 302 
 

We (the entity) give ASX the following information.

Part 1 -- All issues

You must complete the relevant sections (attach sheets if there is not enough space).

 
 1   +Class of +securities          Unlisted Options 
      issued or to be issued 
 
     Number of +securities 
      issued or to be issued 
      (if known) or maximum 
      number which may be 
 2    issued                                     583,000 
 
 3   Principal terms of                          Unlisted Options exercisable 
      the +securities (e.g.                       at $1.108 expiring 13 March 
      if options, exercise                        2022 (subject to vesting conditions) 
      price and expiry date; 
      if partly paid +securities, 
      the amount outstanding 
      and due dates for 
      payment; if +convertible 
      securities, the conversion 
      price and dates for 
      conversion) 
 
 
 
 4     Do the +securities                                            Unlisted Options will rank 
       rank equally in all                                           equally 
       respects from the                                             if converted or exercised into 
       +issue date with an                                           ordinary shares 
       existing +class of 
       quoted +securities? 
 
       If the additional 
       +securities do not 
       rank equally, please 
       state: 
        *    the date from which they do 
 
 
        *    the extent to which they participate for the next 
             dividend, (in the case of a trust, distribution) or 
             interest payment 
 
 
        *    the extent to which they do not rank equally, other 
             than in relation to the next dividend, distribution 
             or interest payment 
 
 5     Issue price or consideration                                             Nil 
 
  6    Purpose of the issue                                         Unlisted Options were issued 
        (If issued as consideration                                  to employees as part of remuneration 
        for the acquisition 
        of assets, clearly 
        identify those assets) 
 
  6a   Is the entity an +eligible                                               Yes 
        entity that has obtained 
        security holder approval 
        under rule 7.1A? 
 
        If Yes, complete sections 
        6b - 6h in relation 
        to the +securities 
        the subject of this 
        Appendix 3B, and comply 
        with section 6i 
 
  6b   The date the security                                       11 May 2018 
        holder resolution 
        under rule 7.1A was 
        passed 
 
       Number of +securities 
        issued without security 
        holder approval under 
  6c    rule 7.1                                                                583,000 
 
  6d   Number of +securities                                       Nil 
        issued with security 
        holder approval under 
        rule 7.1A 
 
  6e   Number of +securities                                       N/A 
        issued with security 
        holder approval under 
        rule 7.3, or another 
        specific security 
        holder approval (specify 
        date of meeting) 
 
  6f   Number of +securities                                       N/A 
        issued under an exception 
        in rule 7.2 
 
  6g   If +securities issued                                       N/A 
        under rule 7.1A, was 
        issue price at least 
        75% of 15 day VWAP 
        as calculated under 
        rule 7.1A.3? Include 
        the +issue date and 
        both values. Include 
        the source of the 
        VWAP calculation. 
 
  6h   If +securities were                                         N/A 
        issued under rule 
        7.1A for non-cash 
        consideration, state 
        date on which valuation 
        of consideration was 
        released to ASX Market 
        Announcements 
 
  6i   Calculate the entity's                                                   Capacity under L.R.7.1 is 36,937,032 
        remaining issue capacity                                                 Capacity under LR7.1A is 26,405,778 
        under rule 7.1 and 
        rule 7.1A - complete 
        Annexure 1 and release 
        to ASX Market Announcements 
 
 7                    +Issue dates                                 26 March 2019 
                       Note: The issue date 
                       may be prescribed 
                       by ASX (refer to the 
                       definition of issue 
                       date in rule 19.12). 
                       For example, the issue 
                       date for a pro rata 
                       entitlement issue 
                       must comply with the 
                       applicable timetable 
                       in Appendix 7A. 
                       Cross reference: item 
                       33 of Appendix 3B. 
                                                                   Number                            +Class 
         Number and +class 
          of all +securities 
          quoted on ASX (including 
          the +securities in 
 8        section 2 if applicable)                                              264,422,398          Ordinary Shares 
                                                                                                    --------------------------------- 
                                                                   Number                          +Class 
 9       Number and +class 
          of all +securities                                                             400,000                 Unlisted Options 
          not quoted on ASX                                                                                      exercisable 
          (including the +securities                                                                             at $0.96 each, 
          in section 2 if applicable)                                                    900,000                 expiring 
                                                                                                                 20 June 2019 
 
                                                                                                                 Unlisted Options 
                                                                                         250,000                 exercisable 
                                                                                                                 at $0.558 each, 
                                                                                                                 expiring 
                                                                                                                 8 August 2019 
                                                                                       1,440,000                 (Remuneration 
                                                                                                                 Options) 
 
                                                                                                                 Unlisted Options 
                                                                                       1,724,015                 exercisable 
                                                                                                                 at $0.543 each, 
                                                                                                                 expiring 
                                                                                                                 7 October 2019 
                                                                                         583,000                 (Remuneration 
                                                                                                                 Options) 
 
                                                                                                                 Unlisted Options 
                                                                                         280,000                 exercisable 
                                                                                                                 at $0.94 each, 
                                                                                         800,000                 expiring 
                                                                                                                 19 May 2020 
                                                                                         100,000                 (Remuneration 
                                                                                                                 Options) 
                                                                                          40,000 
                                                                                                                 Unlisted Options 
                                                                                          30,000                 exercisable 
                                                                                                                 at $1.031 each, 
                                                                                          65,000                 expiring 
                                                                                                                 24 January 2022 
                                                                                                                 (Remuneration 
                                                                                                                 Options) 
 
                                                                                                                 Unlisted Options 
                                                                                                                 exercisable 
                                                                                                                 at $1.031 each, 
                                                                                                                 expiring 
                                                                                                                 24 January 2022 
                                                                                                                 (Remuneration 
                                                                                                                 Options) 
 
                                                                                                                 Performance Rights 
                                                                                                                 - Class 1 
 
                                                                                                                 Performance Rights 
                                                                                                                 - Class 4 
 
                                                                                                                 Performance Rights 
                                                                                                                 - Class 5 
 
                                                                                                                 Performance Rights 
                                                                                                                 - Class 6 
 
                                                                                                                 Performance Rights 
                                                                                                                 - Class 7 
 
                                                                                                                 Performance Rights 
                                                                                                                 - Class 8 
                                                                                                  ----------------------------------- 
 
 10      Dividend policy (in                                       N/A 
          the case of a trust, 
          distribution policy) 
          on the increased capital 
          (interests) 
 
 

Part 2 -- Pro rata issue

 
   11                 Is security holder approval                                      N/A 
                       required? 
 
   12                 Is the issue renounceable                           N/A 
                       or non-renounceable? 
   13                 Ratio in which the +securities                                   N/A 
                       will be offered 
 
 14             +Class of +securities                                     N/A 
                 to which the offer relates 
 
 15             +Record date to determine                                 N/A 
                 entitlements 
 
 16             Will holdings on different                                N/A 
                 registers (or subregisters) 
                 be aggregated for calculating 
                 entitlements? 
 
 17             Policy for deciding entitlements                          N/A 
                 in relation to fractions 
 
 18                          Names of countries in                                     N/A 
                             which the entity has security 
                             holders who will not be 
                             sent new offer documents 
                             Note: Security holders 
                             must be told how their 
                             entitlements are to be 
                             dealt with. 
                             Cross reference: rule 
                             7.7. 
 
 19             Closing date for receipt                                               N/A 
                 of acceptances or renunciations 
 
 20             Names of any underwriters                                 N/A 
 
 21             Amount of any underwriting                                N/A 
                 fee or commission 
 
 22             Names of any brokers to                                                N/A 
                 the issue 
 
 23             Fee or commission payable                                              N/A 
                 to the broker to the issue 
 
 24             Amount of any handling                                    N/A 
                 fee payable to brokers 
                 who lodge acceptances 
                 or renunciations on behalf 
                 of security holders 
 
 25             If the issue is contingent                                N/A 
                 on security holders' approval, 
                 the date of the meeting 
 
 26             Date entitlement and acceptance                           N/A 
                 form and offer documents 
                 will be sent to persons 
                 entitled 
 
 27             If the entity has issued                                  N/A 
                 options, and the terms 
                 entitle option holders 
                 to participate on exercise, 
                 the date on which notices 
                 will be sent to option 
                 holders 
      28           Date rights trading will                                            N/A 
                    begin (if applicable) 
                                                                         ----------------- 
 
          29         Date rights trading will                             N/A 
                      end (if applicable) 
 
   30                 How do security holders                             N/A 
                       sell their entitlements 
                       in full through a broker? 
 
   31                 How do security holders                             N/A 
                       sell part of their entitlements 
                       through a broker and 
                       accept for the balance? 
 
      32                How do security holders                           N/A 
                         dispose of their entitlements 
                         (except by sale through 
                         a broker)? 
 
      33                +Issue date                                       N/A 
 
 

Part 3 -- Quotation of securities

You need only complete this section if you are applying for quotation of securities

 
 34    Type of +securities 
        (tick one) 
 (a)   X   +Securities described in Part 1 
 
 
 
 (b)                  All other +securities 
                       Example: restricted securities at the end of the 
                       escrowed period, partly paid securities that become 
                       fully paid, employee incentive share securities 
                       when restriction ends, securities issued on expiry 
                       or conversion of convertible securities 
 

Entities that have ticked box 34(a)

Additional securities forming a new class of securities

 
 Tick to indicate you are providing 
  the information or documents 
 
 
 35     If the +securities are +equity securities, the 
         names of the 20 largest holders of the additional 
         +securities, and the number and percentage of 
         additional +securities held by those holders 
 
 36     If the +securities are +equity securities, a distribution 
         schedule of the additional +securities setting 
         out the number of holders in the categories 
         1 - 1,000 
         1,001 - 5,000 
         5,001 - 10,000 
         10,001 - 100,000 
         100,001 and over 
 
 37     A copy of any trust deed for the additional +securities 
 

Entities that have ticked box 34(b)

 
 38   Number of +securities                                        N/A 
       for which +quotation 
       is sought 
 
 39   +Class of +securities                                        N/A 
       for which quotation 
       is sought 
 
 40   Do the +securities                                           N/A 
       rank equally in all 
       respects from the +issue 
       date with an existing 
       +class of quoted +securities? 
 
       If the additional +securities 
       do not rank equally, 
       please state: 
        *    the date from which they do 
 
 
        *    the extent to which they participate for the next 
             dividend, (in the case of a trust, distribution) or 
             interest payment 
 
 
        *    the extent to which they do not rank equally, other 
             than in relation to the next dividend, distribution 
             or interest payment 
 
 41                Reason for request                              N/A 
                    for quotation now 
                    Example: In the case 
                    of restricted securities, 
                    end of restriction 
                    period 
 
                    (if issued upon conversion 
                    of another +security, 
                    clearly identify that 
                    other +security) 
 
                                                                   Number   +Class 
 42   Number and +class of                                         N/A      N/A 
       all +securities quoted 
       on ASX (including the 
       +securities in clause 
       38) 
                                                                           --------- 
 
 

Quotation agreement

1 +Quotation of our additional +securities are in ASX's absolute discretion. ASX may quote the +securities on any conditions it decides.

   2             We warrant the following to ASX. 

-- The issue of the +securities to be quoted complies with the law and is not for an illegal purpose.

   --              There is no reason why those +securities should not be granted +quotation. 

-- An offer of the (+) securities for sale within 12 months after their issue will not require disclosure under section 707(3) or section 1012C(6) of the Corporations Act.

Note: An entity may need to obtain appropriate warranties from subscribers for the securities in order to be able to give this warranty

-- Section 724 or section 1016E of the Corporations Act does not apply to any applications received by us in relation to any +securities to be quoted and that no-one has any right to return any +securities to be quoted under sections 737, 738 or 1016F of the Corporations Act at the time that we request that the +securities be quoted.

-- If we are a trust, we warrant that no person has the right to return the +securities to be quoted under section 1019B of the Corporations Act at the time that we request that the +securities be quoted.

3 We will indemnify ASX to the fullest extent permitted by law in respect of any claim, action or expense arising from or connected with any breach of the warranties in this agreement.

4 We give ASX the information and documents required by this form. If any information or document is not available now, we will give it to ASX before +quotation of the +securities begins. We acknowledge that ASX is relying on the information and documents. We warrant that they are (will be) true and complete.

26 March 2019

Sign here: ............................................................ Date: .........................

(Director/Company secretary)

Catherine Grant-Edwards

   Print name:                 ......................................................... 

== == == == ==

Appendix 3B - Annexure 1

Calculation of placement capacity under rule 7.1 and rule 7.1A for (+) eligible entities

Introduced 01/08/12

Part 1

 
                                                        Rule 7.1 - Issues exceeding 15% of capital 
              Step 1: Calculate "A", the base figure from which the placement 
               capacity is calculated 
              Insert number of fully paid 
               ordinary securities on issue 
               12 months before date of 
               issue or agreement to issue                                   259,379,506 
                                                               ----------------------------------------------------------------------------- 
 Add the following:                                                                         125,000 (fully paid ordinary shares 
   *    Number of fully paid ordinary securities issued in                                    issued 29 March 2018 on exercise of 
        that 12 month period under an exception in rule 7.2                                   options) 
                                                                                              727,274 (fully paid ordinary shares 
                                                                                              issued 29 March 2018 on exercise of 
   *    Number of fully paid ordinary securities issued in                                    options) 
        that 12 month period with shareholder approval                                        2,272,728 (fully paid ordinary shares 
                                                                                              issued 4 April 2018 on exercise of options) 
                                                                                              738,346 (fully paid ordinary shares 
   *    Number of partly paid ordinary securities that became                                 issued 14 May 2018 on cashless exercise 
        fully paid in that 12 month period                                                    of options) 
                                                                                              116,586 (fully paid ordinary shares 
                                                                                              issued 29 May 2018 on cashless exercise 
  Note:                                                                                       of options) 
   *    Include only ordinary securities here - other classes                                 90,740 (fully paid ordinary shares issued 
        of equity securities cannot be added                                                  31 May 2018 on cashless exercise of 
                                                                                              options) 
                                                                                              151,234 (fully paid ordinary shares 
   *    Include here (if applicable) the securities the                                       issued 31 May 2018 on cashless exercise 
        subject of the Appendix 3B to which this form is                                      of options) 
        annexed                                                                               200,000 (fully paid ordinary shares 
                                                                                              issued 14 June 2018 on exercise of options) 
                                                                                              10,000 (fully paid ordinary shares issued 
   *    It may be useful to set out issues of securities on                                   14 June 2018 on vesting of Class 7 performance 
        different dates as separate line items                                                rights) 
                                                                                              10,000 (fully paid ordinary shares issued 
                                                                                              26 July 2018 on vesting of Class 6 performance 
                                                                                              rights) 
                                                                                              20,000 (fully paid ordinary shares issued 
                                                                                              26 July 2018 on vesting of Class 8 performance 
                                                                                              rights) 
                                                                                              216,364 (fully paid ordinary shares 
                                                                                              issued 7 November 2018 on cashless exercise 
                                                                                              of options) 
                                                               ----------------------------------------------------------------------------- 
              Subtract the number of fully                                    N/A 
               paid ordinary securities 
               cancelled during that 12 
               month period 
                                                               ----------------------------------------------------------------------------- 
              "A"                                                            264,057,778 
                                                               ----------------------------------------------------------------------------- 
 
 
              Step 2: Calculate 15% of "A" 
              "B"                                                                        0.15 
                                                                                          [Note: this value cannot be 
                                                                                          changed] 
                                                                           --------------------------------------------------------------- 
              Multiply "A" by 0.15                                                       39,608,667 
                                                                           --------------------------------------------------------------- 
              Step 3: Calculate "C", the amount of placement capacity under 
               rule 7.1 that has already been used 
              Insert number of equity securities                                                        356,049 fully paid ordinary 
               issued or agreed to be issued                                                              shares (24 July 2018) 
               in that 12 month period not                                                                8,571 fully paid ordinary shares 
               counting those issued:                                                                     (20 December 2018) 
                *    Under an exception in rule 7.2                                                      1,724,015 unlisted options 
                                                                                                          (27 February 2019) 
                                                                                                          583,000 unlisted options (26 
                *    Under rule 7.1A                                                                      March 2019) 
 
 
                *    With security holder approval under rule 7.1 or rule 
                     7.4 
 
 
               Note: 
                *    This applies to equity securities, unless 
                     specifically excluded - not just ordinary securities 
 
 
                *    Include here (if applicable ) the securities the 
                     subject of the Appendix 3B to which this form is 
                     annexed 
 
 
                *    It may be useful to set out issues of securities on 
                     different dates as separate line items 
                                                                           --------------------------------------------------------------- 
              "C"                                                                        2,671,635 
                                                                           --------------------------------------------------------------- 
              Step 4: Subtract "C" from ["A" x "B"] to calculate remaining 
               placement capacity under rule 7.1 
              "A" x 0.15 
               Note: number must be same as 
               shown in Step 2                                                           39,608,667 
                                                                           --------------------------------------------------------------- 
              Subtract "C" 
               Note: number must be same as 
               shown in Step 3                                                           2,671,635 
                                                                           --------------------------------------------------------------- 
              Total ["A" x 0.15] - "C"                                                   36,937,032 
                                                                           --------------------------------------------------------------- 
 

Part 2

 
             Rule 7.1A - Additional placement capacity for eligible entities 
  Step 1: Calculate "A", the base figure from which the placement 
   capacity is calculated 
  "A" 
   Note: number must be same as shown 
   in Step 1 of Part 1                                264,057,778 
                                                    ------------------------------------- 
  Step 2: Calculate 10% of "A" 
  "D"                                                 0.10 
                                                       Note: this value cannot be changed 
                                                    ------------------------------------- 
  Multiply "A" by 0.10                                26,405,778 
                                                    ------------------------------------- 
  Step 3: Calculate "E", the amount of placement capacity under 
   rule 7.1A that has already been used 
  Insert number of equity securities                  Nil 
   issued or agreed to be issued in 
   that 12 month period under rule 
   7.1A 
   Notes: 
   -- This applies to equity securities 
   - not just ordinary securities 
   -- Include here - if applicable 
   - the securities the subject of 
   the Appendix 3B to which this form 
   is annexed 
   -- Do not include equity securities 
   issued under rule 7.1 (they must 
   be dealt with in Part 1), or for 
   which specific security holder 
   approval has been obtained 
   -- It may be useful to set out 
   issues of securities on different 
   dates as separate line items 
                                                    ------------------------------------- 
  "E"                                                 Nil 
                                                    ------------------------------------- 
              Step 4: Subtract "E" from ["A" x "D"] to calculate remaining placement 
               capacity under rule 7.1A 
              "A" x 0.10 
               Note: number must be same as shown 
               in Step 2                                          26,405,778 
                                                    ------------------------------------- 
              Subtract "E"                                        Nil 
               Note: number must be same as shown 
               in Step 3 
                                                    ------------------------------------- 
              Total ["A" x 0.10] - "E"                            26,405,778 
                                                    ------------------------------------- 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

MSCGMGZFKKZGLZM

(END) Dow Jones Newswires

March 26, 2019 03:00 ET (07:00 GMT)

1 Year Danakali Chart

1 Year Danakali Chart

1 Month Danakali Chart

1 Month Danakali Chart

Your Recent History

Delayed Upgrade Clock